Literature DB >> 22285790

Identification and molecular cloning of a novel amphibian Bowman Birk-type trypsin inhibitor from the skin of the Hejiang Odorous Frog; Odorrana hejiangensis.

Min Wang1, Lei Wang, Tianbao Chen, Brian Walker, Mei Zhou, Dayuan Sui, J Michael Conlon, Chris Shaw.   

Abstract

In this study, an amphibian (Odorrana hejiangensis) skin extract was fractionated by reverse phase HPLC and fractions were screened for trypsin inhibitory activity. Using this initial approach, a novel trypsin inhibitory peptide was detected with an apparent protonated molecular mass of 1804.83 Da, as determined by MALDI-TOF mass spectrometry. It was named Hejiang trypsin inhibitor (HJTI) in accordance. The primary structure of the biosynthetic precursor of HJTI was deduced from a cDNA sequence cloned from a skin-derived cDNA library. The primary structure of the encoded predicted mature active peptide was established as: GAPKGCWTKSYPPQPCS (non-protonated monoisotopic molecular mass--1802.81Da). On the basis of this unequivocal amino acid sequence, a synthetic replicate was synthesized by solid phase Fmoc chemistry. This replicate displayed a moderately potent trypsin inhibition with a K(i) of 388 nM. Bioinformatic analysis of the primary structure of this peptide indicated that it was a member of the Bowman-Birk family of protease inhibitors. The substitutions of Gln-14 and Ser-17 by Lys, resulted in an increase in cationicity and a small increase in potency to a K(i) value of 218nM. Neither HJTI nor its synthetic analog, possessed any significant antimicrobial activity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285790     DOI: 10.1016/j.peptides.2012.01.003

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases.

Authors:  Michelle da Silva Libério; Izabela M D Bastos; Osmindo R Pires Júnior; Wagner Fontes; Jaime M Santana; Mariana S Castro
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

2.  Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide-PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer.

Authors:  Peng Lyu; Lilin Ge; Rui Ma; Ran Wei; Cian M McCrudden; Tianbao Chen; Chris Shaw; Hang Fai Kwok
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

3.  Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.

Authors:  Yuxi Miao; Guanzhu Chen; Xinping Xi; Chengbang Ma; Lei Wang; James F Burrows; Jinao Duan; Mei Zhou; Tianbao Chen
Journal:  Biomolecules       Date:  2019-07-14

4.  A Novel Kunitzin-Like Trypsin Inhibitor Isolated from Defensive Skin Secretion of Odorrana versabilis.

Authors:  Yanjing Dong; Daning Shi; Yuan Ying; Xinping Xi; Xiaoling Chen; Lei Wang; Mei Zhou; Qinan Wu; Chengbang Ma; Tianbao Chen
Journal:  Biomolecules       Date:  2019-06-28

Review 5.  Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications.

Authors:  Agata Gitlin-Domagalska; Aleksandra Maciejewska; Dawid Dębowski
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-25

6.  Vasorelaxin: a novel arterial smooth muscle-relaxing eicosapeptide from the skin secretion of the Chinese piebald odorous frog (Odorrana schmackeri).

Authors:  Yuxin Wu; Lei Wang; Chen Lin; Yan Lin; Mei Zhou; Liang Chen; Brian Connolly; Yingqi Zhang; Tianbao Chen; Chris Shaw
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

7.  A Novel Trypsin Inhibitor-Like Cysteine-Rich Peptide from the Frog Lepidobatrachus laevis Containing Proteinase-Inhibiting Activity.

Authors:  Yu-Wei Wang; Ji-Min Tan; Can-Wei Du; Ning Luan; Xiu-Wen Yan; Ren Lai; Qiu-Min Lu
Journal:  Nat Prod Bioprospect       Date:  2015-09-02

Review 8.  Host Defense Peptides from Asian Frogs as Potential Clinical Therapies.

Authors:  Vineeth T V Kumar; David Holthausen; Joshy Jacob; Sanil George
Journal:  Antibiotics (Basel)       Date:  2015-03-30

9.  Novel Kazal-type proteinase inhibitors from the skin secretion of the Splendid leaf frog, Cruziohyla calcarifer.

Authors:  Carolina Proaño-Bolaños; Renjie Li; Mei Zhou; Lei Wang; Xinping Xi; Elicio E Tapia; Luis A Coloma; Tianbao Chen; Chris Shaw
Journal:  EuPA Open Proteom       Date:  2017-02-27

10.  A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea.

Authors:  Luyao Zhang; Xiaoling Chen; Yue Wu; Mei Zhou; Chengbang Ma; Xinping Xi; Tianbao Chen; Brian Walker; Chris Shaw; Lei Wang
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.